Abstract:A series of novel 1,3-bisubstituted and 1, 3,9-trisubstituted beta-carboline derivatives was synthesized from the starting material L-tryptophan. Cytotoxic activities of these compounds were investigated in vitro. The results showed that 1,3,9-trisubstituted beta-carboline derivatives had higher cytotoxic activities in vitro than the corresponding 1,3-bisubstituted compounds. Among all the synthesized 1,3,9-trisubstituted P-carboline derivatives, the compounds with a methyl substituent at position-1 displayed more potent cytotoxic activities, furthermore compound 5e having an ethoxycarbonyl substituent at position-3 and a pentafluorobenzyl at position-9, respectively, was found to be the most potent compounds of this series with IC50 value of 4 uM against BGC-823 cell lines. These data suggested that (1) the cytotoxic potencies of beta-carboline derivatives were enhanced by the introduction of appropriate substituents into position-1 and position-9 in beta-carboline; (2) the beta-carboline structure might be an important basis for the design and synthesis of new antitumor drugs; (3) the methyl substituent at position-1, the pentafluorobenzyl group at position-9 and the ethoxycarbonyl substituent at position-3 were the optimal combination for the improvement of cytotoxic activity of the P-carboline derivatives. (c) 2004 Elsevier SAS. All rights reserved.

Synthesis and biological evaluation of novel 3,9-substituted β-carboline derivatives as anticancer agents

Synthesis and Structure-Activity Relationship Studies of Novel 3,9-Substituted Α-Carboline Derivatives with High Cytotoxic Activity Against Colorectal Cancer Cells

Synthesis and Cytotoxicity of 1,6,8,9-Substituted Α-Carboline Derivatives

Design, synthesis and mechanism of action of novel 1,9-disubstituted beta-carboline derivatives as antitumor agents

Synthesis and antitumor activity of novel N-substituted tetrahydro-β-carboline-imidazolium salt derivatives.

Synthesis and in Vitro Cytotoxic Evaluation of Novel 3,4, 5-Trimethoxyphenyl Substituted Beta-Carboline Derivatives

Design, Synthesis, and Antitumor Activity of Β-Carboline- Benzimidazole Hybrids

Synthesis and biological evaluation of a novel class of beta-carboline derivatives

Selective and effective anticancer agents: Synthesis, biological evaluation and structure–activity relationships of novel carbazole derivatives

Synthesis, Crystal Structure and Antitumor Activity of Novel 5-Chloro-β-carboline Derivatives

Synthesis and biological evaluation of 1,9-disubstituted β-carbolines as potent DNA intercalating and cytotoxic agents.

Synthesis and in Vitro Cytotoxic Evaluation of 1,3-Bisubstituted and 1,3,9-Trisubstituted Beta-Carboline Derivatives

Synthesis and Antitumor Activities of Β-Carboline Derivatives

Design, Synthesis and Biological Activity Evaluation of β-Carboline Derivatives Containing Nitrogen Heterocycles

Synthesis, cytotoxic activities and DNA binding properties of β-carboline derivatives.

Design, Synthesis, and Biological Evaluation of Novel Γ-Carboline Ketones As Anticancer Agents

Synthesis And Biological Evaluation Of Novel Benzothiazole-2-Thiol Derivatives As Potential Anticancer Agents

Synthesis and Antitumor Activity of Novel N-substituted Carbazole Imidazolium Salt Derivatives

Novel Benzothiazole, Benzimidazole and Benzoxazole Derivatives As Potential Antitumor Agents: Synthesis and Preliminary in Vitro Biological Evaluation

Synthesis and biological evaluation of novel 3,6- amide and thioamide substituted- 2,3,4,9-tetrahydro-1H-carbazoles for anti-cancer activity

Synthesis and Cytotoxic Evaluation of Novel Dimethyl [1,1′‐biphenyl]‐2,2′‐dicarboxylates Bearing 1,3,4‐thiadiazole Moieties